Skip to content
Open access

Respiratory syncytial virus in adults aged ≥ 50 years in the Netherlands: a database and time-series modelling analysis (2013-2020).

Oct 2026 · Infection · 0 citations · 28 references
Medicine

Abstract

Purpose

Respiratory syncytial virus (RSV) is a significant yet historically understudied contributor to acute respiratory infection (ARI) in older adults. This study aimed to quantify ARI-associated hospital admissions and estimate RSV-related burden of disease in secondary care in the Netherlands using time-series modelling.

Methods

This retrospective cohort study (1 July 2013 to 29 February 2020) utilised routinely collected primary and secondary care data from the PHARMO Data Network. ARI-associated hospital admissions in patients aged ≥ 50 years, identified via International Classification of Diseases (ICD)-10 codes, were described in terms of patient and clinical characteristics and healthcare resource utilisation. The number and annual rate of RSV- and influenza-associated ARI and lower respiratory tract disease (LRTD) hospital admissions by age and risk group were estimated using a Quasi-Poisson regression model.

Results

There were 97,279 ARI admissions in 63,420 patients. Estimated RSV-associated ARI hospital admission rates ranged from 0.70/1,000 person-years (PY) to 1.92/1,000 PY in adults aged ≥ 50 and ≥ 75, respectively. RSV-associated LRTD admissions varied from 0.63/1,000 PY to 1.73/1,000 PY in these groups. Hospitalisation rates were higher in high-risk individuals. Estimated RSV admissions were up to six times higher than observed. During peak months, up to 30% of ARI (20% of LRTD) admissions were attributable to RSV. RSV-coded admissions had an average length of stay of 7-8 days, and 30% of patients experienced all-cause readmission within 90 days.

Conclusion

The substantial hospitalisation burden of RSV calls for prioritisation of RSV prevention strategies, including vaccination, alongside influenza and other causes of ARI and LRTD.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.